Yu-Jia Chang

21PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 13, 2026
Homer3 Promotes Aggressive Phenotypes in Triple-Negative Breast Cancer Through Cell Cycle- and MYC-Associated Programs.

|Dec 23, 2023
Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.

Yi-Hsuan Lai, Yu-Tien Chang, Yu-Jia Chang

|Dec 11, 2023
The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression.

Yu-Jia Chang, G M Shazzad Hossain Prince, Po-Li Wei

|Oct 28, 2023
CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

Cheng-Chin Lee, Kuei-Yen Tsai, Ai-Wei Lee

|Jul 29, 2023
2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.

Kuei-Yen Tsai, Po-Li Wei, Cheng-Chin Lee

|Jul 14, 2023
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig

Pageof 4

Frequent Collaborators

9 joint publications

Po-Li Wei

5 joint publications

Uyanga Batzorig

4 joint publications

Chin-Sheng Hung

4 joint publications

Kuei-Yen Tsai